• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PBMCs 非生产性暴露于 SARS-CoV-2 会诱导细胞内固有免疫反应。

Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.

机构信息

Institute of Virology, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Berlin Institute of Health, Berlin, Germany.

出版信息

Mol Syst Biol. 2022 Aug;18(8):e10961. doi: 10.15252/msb.202210961.

DOI:10.15252/msb.202210961
PMID:35975552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382356/
Abstract

Cell-intrinsic responses mounted in PBMCs during mild and severe COVID-19 differ quantitatively and qualitatively. Whether they are triggered by signals emitted by productively infected cells of the respiratory tract or result from physical interaction with virus particles remains unclear. Here, we analyzed susceptibility and expression profiles of PBMCs from healthy donors upon ex vivo exposure to SARS-CoV and SARS-CoV-2. In line with the absence of detectable ACE2 receptor expression, human PBMCs were refractory to productive infection. RT-PCR experiments and single-cell RNA sequencing revealed JAK/STAT-dependent induction of interferon-stimulated genes (ISGs) but not proinflammatory cytokines. This SARS-CoV-2-specific response was most pronounced in monocytes. SARS-CoV-2-RNA-positive monocytes displayed a lower ISG signature as compared to bystander cells of the identical culture. This suggests a preferential invasion of cells with a low ISG baseline profile or delivery of a SARS-CoV-2-specific sensing antagonist upon efficient particle internalization. Together, nonproductive physical interaction of PBMCs with SARS-CoV-2- and, to a much lesser extent, SARS-CoV particles stimulate JAK/STAT-dependent, monocyte-accentuated innate immune responses that resemble those detected in vivo in patients with mild COVID-19.

摘要

在轻症和重症 COVID-19 期间,PBMC 中发生的细胞内在反应在数量和质量上有所不同。它们是由呼吸道中感染细胞产生的信号触发的,还是由于与病毒颗粒的物理相互作用而产生的,目前尚不清楚。在这里,我们分析了健康供体的 PBMC 在体外暴露于 SARS-CoV 和 SARS-CoV-2 时的易感性和表达谱。由于检测不到 ACE2 受体的表达,人类 PBMC 对有性感染具有抗性。RT-PCR 实验和单细胞 RNA 测序揭示了 JAK/STAT 依赖性诱导干扰素刺激基因(ISGs)但不诱导促炎细胞因子。这种 SARS-CoV-2 特异性反应在单核细胞中最为明显。与同一培养物中的旁观者细胞相比,SARS-CoV-2-RNA 阳性单核细胞的 ISG 特征较低。这表明在有效的颗粒内化后,优先入侵具有低 ISG 基线特征的细胞,或者递呈 SARS-CoV-2 特异性感应拮抗剂。总之,PBMC 与 SARS-CoV-2 的非生产性物理相互作用,以及在较小程度上与 SARS-CoV 颗粒的相互作用,刺激了 JAK/STAT 依赖性、以单核细胞为重点的先天免疫反应,这些反应类似于在轻症 COVID-19 患者体内检测到的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/67ffedc6408a/MSB-18-e10961-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/fec96e6a4135/MSB-18-e10961-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/15793384f4ce/MSB-18-e10961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/2ca9f733e155/MSB-18-e10961-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/209361d8c7f0/MSB-18-e10961-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/f52a5901ebb6/MSB-18-e10961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/8f1efa090e69/MSB-18-e10961-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/dfde2ad4d4c4/MSB-18-e10961-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/1d7bb56517b6/MSB-18-e10961-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/cffcf7b0800e/MSB-18-e10961-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/67ffedc6408a/MSB-18-e10961-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/fec96e6a4135/MSB-18-e10961-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/15793384f4ce/MSB-18-e10961-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/2ca9f733e155/MSB-18-e10961-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/209361d8c7f0/MSB-18-e10961-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/f52a5901ebb6/MSB-18-e10961-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/8f1efa090e69/MSB-18-e10961-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/dfde2ad4d4c4/MSB-18-e10961-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/1d7bb56517b6/MSB-18-e10961-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/cffcf7b0800e/MSB-18-e10961-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b787/9382356/67ffedc6408a/MSB-18-e10961-g009.jpg

相似文献

1
Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.PBMCs 非生产性暴露于 SARS-CoV-2 会诱导细胞内固有免疫反应。
Mol Syst Biol. 2022 Aug;18(8):e10961. doi: 10.15252/msb.202210961.
2
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
3
Human Nasal and Lung Tissues Infected with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.人鼻腔和肺部组织感染 SARS-CoV-2 提供了在上呼吸道和下呼吸道中不同组织特异性和病毒特异性先天免疫反应的见解。
J Virol. 2021 Jun 24;95(14):e0013021. doi: 10.1128/JVI.00130-21.
4
Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒蛋白在人上皮细胞中抑制 IFN-α JAK/STAT 通路。
Viruses. 2022 Mar 23;14(4):667. doi: 10.3390/v14040667.
5
SARS-CoV-2 Induces a More Robust Innate Immune Response and Replicates Less Efficiently Than SARS-CoV in the Human Intestines: An Ex Vivo Study With Implications on Pathogenesis of COVID-19.SARS-CoV-2 在人体肠道中诱导更强的先天免疫反应,复制效率低于 SARS-CoV:一项对 COVID-19 发病机制具有启示意义的离体研究。
Cell Mol Gastroenterol Hepatol. 2021;11(3):771-781. doi: 10.1016/j.jcmgh.2020.09.017. Epub 2020 Oct 1.
6
SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.SARS-CoV-2 分离株在人免疫细胞中的复制能力受损,但在肺上皮细胞中的复制能力和诱导先天免疫能力存在差异。
Microbiol Spectr. 2021 Sep 3;9(1):e0077421. doi: 10.1128/Spectrum.00774-21. Epub 2021 Aug 11.
7
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.SARS-CoV-2 和 SARS-CoV 在人肺中的比较复制和免疫激活特征:一项具有 COVID-19 发病机制意义的离体研究。
Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.
8
Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients.疫苗初免的 COVID-19 患者外周血中的干扰素反应及干扰素反应基因分析。
Front Immunol. 2024 Jan 10;14:1315602. doi: 10.3389/fimmu.2023.1315602. eCollection 2023.
9
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
10
Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.《COVID-19 中的每日病毒动力学和固有及适应性免疫反应评估:病例系列》。
mSphere. 2020 Nov 11;5(6):e00827-20. doi: 10.1128/mSphere.00827-20.

引用本文的文献

1
Peripheral immune progression to long COVID is associated with mitochondrial gene transcription: A meta-analysis.外周免疫进展为长期新冠与线粒体基因转录相关:一项荟萃分析。
Mitochondrion. 2025 Jul 28;85:102072. doi: 10.1016/j.mito.2025.102072.
2
A systems biology approach unveils different gene expression control mechanisms governing the immune response genetic program in peripheral blood mononuclear cells exposed to SARS-CoV-2.一种系统生物学方法揭示了在暴露于SARS-CoV-2的外周血单核细胞中,控制免疫反应遗传程序的不同基因表达调控机制。
PLoS One. 2024 Dec 5;19(12):e0314754. doi: 10.1371/journal.pone.0314754. eCollection 2024.
3

本文引用的文献

1
Highly restricted SARS-CoV-2 receptor expression and resistance to infection by primary human monocytes and monocyte-derived macrophages.高限制的 SARS-CoV-2 受体表达和对原代人单核细胞和单核细胞衍生的巨噬细胞感染的抗性。
J Leukoc Biol. 2022 Sep;112(3):569-576. doi: 10.1002/JLB.4COVA1121-579RR. Epub 2022 May 27.
2
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.奈玛特韦片/利托那韦片组合包装口服药用于伴有进展为重症高风险因素的 COVID-19 门诊患者。
N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study.
双醋瑞因可降低炎性小体激活和新型冠状病毒复制:一项概念验证性转化研究。
Front Pharmacol. 2024 Oct 7;15:1402032. doi: 10.3389/fphar.2024.1402032. eCollection 2024.
4
Multiple Mechanisms of Action of Sulfodyne, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.天然抗氧化剂磺胺嘧啶对SARS-CoV-2感染致病作用的多种作用机制
Antioxidants (Basel). 2024 Sep 4;13(9):1083. doi: 10.3390/antiox13091083.
5
Metacell-based differential expression analysis identifies cell type specific temporal gene response programs in COVID-19 patient PBMCs.基于元细胞的差异表达分析鉴定了 COVID-19 患者 PBMC 中细胞类型特异性的时间基因反应程序。
NPJ Syst Biol Appl. 2024 Apr 5;10(1):36. doi: 10.1038/s41540-024-00364-2.
6
Altered mitochondrial respiration in peripheral blood mononuclear cells of post-acute sequelae of SARS-CoV-2 infection.新型冠状病毒肺炎感染后急性后遗症患者外周血单个核细胞线粒体呼吸的改变
Mitochondrion. 2024 Mar;75:101849. doi: 10.1016/j.mito.2024.101849. Epub 2024 Feb 9.
7
Development of an In Vitro Model of SARS-CoV-Induced Acute Lung Injury for Studying New Therapeutic Approaches.开发用于研究新治疗方法的严重急性呼吸综合征冠状病毒诱导的急性肺损伤体外模型。
Antioxidants (Basel). 2022 Sep 27;11(10):1910. doi: 10.3390/antiox11101910.
8
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients.在 COVID-19 患者中,功能障碍的嘌呤能信号与疾病严重程度相关。
Front Immunol. 2022 Sep 30;13:1012027. doi: 10.3389/fimmu.2022.1012027. eCollection 2022.
9
Monocyte-crosstalk drives interferon-mediated signaling following SARS-CoV-2 exposure.单核细胞相互作用驱动 SARS-CoV-2 暴露后的干扰素介导的信号转导。
Mol Syst Biol. 2022 Sep;18(9):e11256. doi: 10.15252/msb.202211256.
卡司瑞韦单抗和伊德韦单抗联合治疗住院 COVID-19 患者(RECOVERY):一项随机、对照、开放标签、平台试验。
Lancet. 2022 Feb 12;399(10325):665-676. doi: 10.1016/S0140-6736(22)00163-5.
4
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences.绝对定量单个 SARS-CoV-2 RNA 分子为感染动力学和变异差异提供了一个新的范例。
Elife. 2022 Jan 20;11:e74153. doi: 10.7554/eLife.74153.
5
A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface.SARS-CoV-2 在免疫-上皮界面诱导病毒特异性单核细胞炎症表型。
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1). doi: 10.1073/pnas.2116853118.
6
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis.SARS-CoV-2 感染引发成纤维细胞增生性巨噬细胞反应和肺纤维化。
Cell. 2021 Dec 22;184(26):6243-6261.e27. doi: 10.1016/j.cell.2021.11.033. Epub 2021 Nov 27.
7
The reactome pathway knowledgebase 2022.反应体通路知识库2022版。
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692. doi: 10.1093/nar/gkab1028.
8
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.REGEN-COV 抗体组合在门诊 COVID-19 患者中的应用及结果。
N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29.
9
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.叙利亚仓鼠的时间组学分析揭示了细胞效应器对中等严重程度 COVID-19 的反应。
Nat Commun. 2021 Aug 11;12(1):4869. doi: 10.1038/s41467-021-25030-7.
10
Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.严重 COVID-19 康复与髓系细胞免疫调节表型的及时获得有关。
Front Immunol. 2021 Jun 23;12:691725. doi: 10.3389/fimmu.2021.691725. eCollection 2021.